Core Points - The controlling shareholder and former chairman of Meihua Biological, Meng Qingshan, has been sentenced to three years in prison with a five-year probation for manipulating the securities market [2][5] - Following a penalty of 122 million yuan, the court also imposed a fine on Meng Qingshan [2][5] - As of November 7, Meihua Biological's stock closed at 11.52 yuan per share, with a market capitalization of 32.3 billion yuan [2] Summary by Sections - Legal Proceedings: Meng Qingshan received a written notification from the Intermediate People's Court of Langfang, Hebei Province, regarding his conviction for manipulating the securities market, resulting in a three-year prison sentence and a fine [5][6] - Background of the Case: Meng Qingshan retired from his position in the company in January 2017 and has not held any official role since then, only exercising shareholder rights at meetings [5][6] - Investigation Details: The China Securities Regulatory Commission (CSRC) initiated an investigation into Meng Qingshan and the then-secretary of the board, Yang Huixing, for their involvement in manipulating the stock price during a non-public offering in 2013 [6][7] - Manipulation Tactics: The investigation revealed that Meng Qingshan and Yang Huixing engaged in actions to ensure the success of the non-public offering by manipulating stock prices and controlling information dissemination [7][8] - Financial Impact: The illegal gains from their actions amounted to 196 million yuan for the involved trust, with actual losses of 140 million yuan incurred by a shareholder [7][8]
操纵证券市场!300亿A股控股股东,被判刑